Company profilePharmaceutical#1000 of 1,318 in Pakistan✓ No DRAP alerts

Chiesi Pharmaceuticals (Pvt) Ltd DSL: 05-352-0058-0161D

Pharmaceutical company · 4 brands · 8 molecules

Ranked #23 of 24 companies in Hormone Regulators

4 registered products 8 pharmaceutical brands 8 distinct molecules 0 DRAP alerts

Company overview

4
registered products
8
pharmaceutical brands
8
distinct molecules
2
therapeutic classes
0
DRAP alerts

Chiesi Pharmaceuticals (Pvt) Ltd DSL: 05-352-0058-0161D is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 4 product registrations across 8 distinct molecules. Its portfolio is concentrated in Hormone Regulators and Gonadotropins And Other Ovulation Stimulants. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Chiesi

9 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

9
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
20269

Top molecules by brand count

Poractant Alfa ...... 240 Mg1 brand
Pulmonary Surfactant Of Natural Origin ...... 80 Mg1 brand
Clomiphene1 brand
Clomifene1 brand
Clomiphene ...... 50 Mg1 brand
Ipratropium Bromide 4Mg1 brand
Beclomethasone ...... 0.05 Mg1 brand
Beclomethasone ...... 0.250 Mg1 brand

Therapeutic classes

Hormone Regulators · 1Gonadotropins And Other Ovulation Stimulants · 1

Conditions treated

Infertility · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official6 products · Rs 430.29 – Rs 58,245
DVAGO1 products · Rs 693 – Rs 693
Servaid1 products · Rs 535 – Rs 535
Median across source: Rs 693

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

NABIQASIM INDUSTRIES (PVT) LTD. holds 196 molecules not in this portfolio
2 MiuAcefyllin PiperazineAcefyllineAcetaminophinAcetylsalicyclic AcidAcyclovir
PLATINUM PHARMACEUTICALS (PVT.) LTD. holds 124 molecules not in this portfolio
AlfacalcidolAmlodipineAmlodipine Base 10MgAmlodipine Base………….5MgAripiprazoleArtemether
INNVOTEK PHARMACEUTICALS holds 44 molecules not in this portfolio
AcetazolamideAcyclovirArtemetherAscorbic AcidAzithromycinBisoprolol

Get the full profile for Chiesi

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.